13.9. Analysis.
Comparison 13 Intramuscular prostaglandin versus injectable uterotonics (subgroups by low‐ and high‐risk pregnancy), Outcome 9 Any side‐effect.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.